Related Experiment Video
Updated: May 16, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Artonin E mediates MCL1 down-regulation and sensitizes lung cancer cells to anoikis
Ekkarat Wongpankam1, Preedakorn Chunhacha, Varisa Pongrakhananon
1Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulakongkorn University, Phatumwan, Bangkok, 10330 Thailand.
Background:
Anoikis, or detachment-induced apoptosis, is recognized as a key inhibitory process of cancer metastasis. Since lung cancer cells possess an ability to resist anoikis, resulting in a high rate of metastasis and death, the present study aimed to investigate the possible anoikis-sensitizing effect of artonin E (AE).
Materials And Methods:
AE was extracted from bark of Artocarpus gomezianus. Anoikis sensitization of AE was investigated in H460, A549 and H292 human lung cancer cells. The level of anoikis-related proteins was determined by western blot analysis and viable cells were measured by the 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) method.
Results:
AE was shown to enhance anoikis of H460 cells in a dose-dependent manner. We investigated the underlying mechanisms of AE on anoikis sensitization and found that AE sensitized the cells by down-regulating the anti-apoptotic myeloid leukemia cell sequence-1 (MCL1) protein but had no significant effect on other proteins of the B-cell lymphoma-2 (BCL2) family, including BCL2 and BCL2-associated X protein (BAX). Anoikis sensitization of AE was consistently observed in A549 and H292 lung cancer cells.
Conclusion:
The present study demonstrates a novel activity of AE on lung cancer cell anoikis for the first time which might lead to the development of a new strategy for lung cancer therapy.
Insights
Artonin E (AE) enhances anoikis, or detachment-induced apoptosis, in lung cancer cells. This compound offers a potential new therapeutic strategy by sensitizing cancer cells to anoikis, thereby inhibiting metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Anoikis, a crucial process inhibiting cancer metastasis, is often resisted by lung cancer cells.
- Lung cancer's resistance to anoikis contributes to high metastasis rates and mortality.
- Artonin E (AE) is investigated for its potential to sensitize lung cancer cells to anoikis.
Purpose of the Study:
- To investigate the anoikis-sensitizing effect of Artonin E (AE) on human lung cancer cells.
- To explore the molecular mechanisms underlying AE's impact on anoikis.
- To evaluate AE as a potential therapeutic agent for lung cancer.
Main Methods:
- Artonin E (AE) was extracted from Artocarpus gomezianus bark.
- Anoikis sensitization was assessed in H460, A549, and H292 lung cancer cell lines.
- Protein levels of anoikis-related factors were analyzed via western blot; cell viability was measured using the XTT assay.
Main Results:
- AE demonstrated a dose-dependent enhancement of anoikis in H460 lung cancer cells.
- AE sensitized cells by down-regulating myeloid leukemia cell sequence-1 (MCL1), an anti-apoptotic protein.
- Significant anoikis sensitization by AE was observed across H460, A549, and H292 cell lines, with no major impact on BCL2 or BAX.
Conclusions:
- Artonin E exhibits a novel activity in promoting lung cancer cell anoikis.
- AE's ability to sensitize lung cancer cells to anoikis presents a potential new therapeutic strategy.
- This research may pave the way for novel treatments targeting lung cancer metastasis.
Related Concept Videos
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
PI3K/mTOR/AKT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...